Antiwei Granules
- Generic Name
- Antiwei Granules
A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold
Phase 3
Recruiting
- Conditions
- Common Cold
- Interventions
- Drug: Antiwei Granules Placebo
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 480
- Registration Number
- NCT06697886
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
🇨🇳changsha Hospital Affiliated to Hunan University, Changsha, China
🇨🇳Chengdu Pidu District Hospital of TCM, Chengdu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath